OIS@ASRS

Anthony P. Adamis, MD Senior Vice President and Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science at Genentech, recounts the influence famous…

Andrew Gitkin, managing director and head of West Coast biotechnology investment banking at Piper Jaffray, says ophthalmology remains one of the “top two or three”…

Jonathan Norris, a managing director for SVB’s Healthcare practice, says fund-raising numbers for biotech start-ups is strong while Medtech is seeing a decline. While VCs…

Tarek S. Hassan, M.D., Professor of Ophthalmology at Oakland University William Beaumont School of Medicine and Fellowship Director at Associated Retinal Consultants in Royal Oak,…

Jay S. Duker, MD, is the Director of the New England Eye Center (NEEC), Professor and Chairman of Ophthalmology at Tufts Medical Center and Tufts…

New ASRS President Mark S. Humayun, MD, PhD, shares the challenges of entrepreneurship in innovation. Co-Inventor of the world’s first FDA approved artificial retinal prosthesis…

Tracy Saxton, investment director at Roche Venture Fund, began her career at the research bench but quickly founder he way into the corporate side working…

Adnan Butt, senior biotechnology analyst at RBC Capital Markets, says interest in ophthalmology is on the rise for products targeting both the posterior and anterior…

Frederic Guerard, worldwide business franchise head, ophthalmology for Novartis, sits down with OIS TV to explain how the “conscious uncoupling” with Alcon will impact Novartis’…

Many see optical coherence tomography (OCT) angiography as a promising new technology, but David Huang, MD, PhD, Peterson professor of ophthalmology at the Casey Eye…

OIS founder and co-chair Emmett Cunningham Jr., MD, welcomes attendees to the first annual Ophthalmology Innovation Summit held prior to the annual meeting of the…